Impact Analytical
Private Company
Funding information not available
Overview
Impact Analytical is a well-established, privately-held Contract Research Organization (CRO) specializing in analytical testing services. With over 25 years of operation, it has built a reputation for reliability and technical expertise, serving global clients in highly regulated sectors such as pharma, medical devices, and consumer goods. The company's business model is entirely service-based, generating revenue through a vast portfolio of testing protocols, including chromatography, mass spectrometry, spectroscopy, and thermal analysis. Its strategic focus is on addressing urgent regulatory and safety concerns, such as contaminant detection (e.g., benzene, DEG/EG, PFAS), which positions it as a critical partner for manufacturers navigating complex compliance landscapes.
Technology Platform
Comprehensive suite of analytical chemistry techniques including chromatography (GC, HPLC, IC), mass spectrometry (GC-MS, LC-MS/MS, HRMS), spectroscopy (FT-IR, NMR), and thermal analysis (DSC, TGA). Expertise lies in method development, validation, and application under GLP/cGMP standards for material characterization, contaminant detection, and regulatory compliance.
Opportunities
Risk Factors
Competitive Landscape
Impact Analytical competes in a fragmented market against other independent contract labs, specialized testing firms, and large, global Contract Research Organizations (CROs). Its differentiation is based on cross-industry expertise, scientist-led customer service, and responsiveness to urgent regulatory testing needs. Competition is driven by technical capabilities, turnaround time, price, and quality reputation.